Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Interim Statements of Operations and Comprehensive Loss

v3.10.0.1
Condensed Consolidated Interim Statements of Operations and Comprehensive Loss - USD ($)
3 Months Ended
Jun. 30, 2018
Jun. 30, 2017
Sales $ 501,333 $ 87,520
Cost of Sales 253,163 29,300
Gross Margin 248,170 58,220
Operating expenses    
Sales and marketing 542,659 445,525
Research and development 676,743 685,909
General and administrative 979,479 627,606
Share-based compensation expense (Note 11) 595,412 251,048
Amortization (Note 4) 71,053 92,949
Depreciation (Note 7) 17,595 24,552
Total operating expenses 2,882,941 2,127,589
Other (income) expense    
Foreign exchange (41,134) 98,561
Accretion expense (Note 8) 134,251 0
Fair value adjustment (Note 8) 44,087 0
Gain on mark to market reevaluation (2,048,697) 0
Other expense 37,420 72,588
Total other (income) expenses (1,874,073) 171,149
Net loss and comprehensive loss for the period $ (760,698) $ (2,240,518)
Loss per share – basic $ 0.00 $ (0.02)
Loss per share – diluted $ 0.00 $ (0.02)
Weighted average number of shares outstanding – basic 257,509,141 96,959,284
Weighted average number of shares outstanding – diluted 257,509,141 96,959,284